Magnesium and Migraines After Menopause, What a Human Trial Found

Shilajit's most specific, evidence backed role in a woman's mineral status is carrying magnesium and other trace minerals into the body through the chelating action of its fulvic acid, and that role connects directly to a real, human, placebo controlled finding on migraines. In a 12 week trial, oral magnesium cut migraine attack frequency by 41.6 percent against 15.8 percent for placebo. A separate controlled trial found postmenopausal women lose more magnesium through urine than premenopausal women, and that estrogen therapy corrects it. Put those two findings together and a pattern most women are never told about starts to take shape.
Why do migraines often change after menopause?

For many women, migraines tied closely to the monthly hormone cycle genuinely ease once menopause is complete and hormone levels stop swinging. That improvement is real, and it is also where a lot of women's understanding of their own migraines stops.
What gets missed is that a second, quieter driver keeps running long after the hormonal swings settle down. Nutrient status, magnesium specifically, is one of the best studied pieces of that second driver, and it does not depend on which direction her hormones happened to move that week.
The magnesium connection nobody mentions
- Migraine patients as a group tend to have lower magnesium levels than people without migraine, measured in blood and in brain tissue in various studies
- Magnesium is involved in stabilizing nerve cell excitability and regulating blood vessel tone, both directly relevant to how a migraine attack develops
- A woman whose migraines shifted after menopause but never fully disappeared may be looking at a nutrient story, not only a hormone story
That distinction matters, because a hormone story and a nutrient story call for different next steps.
Does magnesium actually help with migraines?
The strongest single piece of evidence here is a multi-center, placebo controlled, double-blind trial published in the journal Cephalalgia. Researchers gave 81 migraine patients, ages 18 to 65, either 600 milligrams of oral magnesium daily or a placebo, for 12 weeks.
- In weeks 9 through 12, attack frequency fell 41.6 percent in the magnesium group compared with baseline
- The placebo group fell only 15.8 percent over the same period
- The difference between the two groups was statistically significant
A 2015 systematic review pulled together the available controlled trials on oral magnesium for migraine prevention and concluded the evidence, while not uniform across every study, is consistent enough to support magnesium as a real preventive option worth considering.
What the evidence does not yet show
Not every magnesium trial for migraine has shown a benefit, and the form of magnesium used varies by study. This is a real, replicated signal, not a guaranteed result for every woman who takes a magnesium supplement. The honest read is that magnesium status is one legitimate lever in a condition with several, not a single fix.
Why does magnesium run low specifically after menopause?

Here is the part that ties menopause itself to the magnesium story, and it comes from a controlled human trial, not a guess.
Researchers measured magnesium homeostasis in 48 premenopausal women and 54 early postmenopausal women. The postmenopausal group excreted significantly more magnesium in their urine, 467 versus 355 millimoles per mole of creatinine. The postmenopausal women were then randomly split, some receiving two years of estrogen substitutional therapy, some placebo.
| Group | 24 hour urinary magnesium excretion |
|---|---|
| Premenopausal women | 355 mmol per mol creatinine |
| Postmenopausal women, placebo | 467 mmol per mol creatinine |
| Postmenopausal women, 2 years of estrogen therapy | Returned to premenopausal level |
The estrogen treated group's excretion dropped back down to the premenopausal range, a statistically significant reversal. Estrogen appears to help the body hold onto magnesium, and losing it at menopause measurably increases how much magnesium leaves the body.
The direct estrogen link, in a controlled human trial
This is not a theory pieced together from unrelated data. It is one trial, tracking the same women, before and after a randomized treatment, with a clear before and after number. Add to that the separate, well known fact that magnesium absorption tends to decline with age generally, and a woman past menopause is working against two forces at once, not one.
How does fulvic acid help the body absorb magnesium?
Getting more magnesium into the diet is only half the story. Getting it absorbed is the other half, and that is where shilajit's fulvic acid does its specific work.
- Fulvic acid is a small, negatively charged molecule that binds minerals, including magnesium, into a chelated form
- That chelated form travels across the intestinal wall through the body's normal mineral transport channels
- Standard magnesium salts can cause gastrointestinal upset in a meaningful share of people who try them, a common reason supplementation gets abandoned
This is a general mineral delivery mechanism, described from shilajit's known composition and chemistry, not a result measured against migraines directly. Keeping that boundary honest is the whole point of this section.
What does the research on shilajit and magnesium actually show?

No study, human or animal, has tested shilajit against migraine frequency, migraine severity, or magnesium status in migraine patients specifically. Saying otherwise would borrow evidence from a question nobody has actually asked.
What does exist is a body of composition and safety research describing shilajit as a whole food mineral resin whose fulvic acid fraction is a documented mineral chelator, generally well tolerated across the human and animal studies conducted on it.
What this does and does not prove
It does not prove shilajit treats or prevents migraines. It does not prove shilajit corrects the postmenopausal magnesium loss measured in the estrogen trial above. What it supports is a narrower, honest claim, that shilajit is a whole food route to the magnesium and trace minerals the two trials above are actually built around.
Where does shilajit fit for a woman with migraines?
Shilajit is not positioned here as a migraine treatment, and no claim in this article says it is.
- Shilajit does not treat, cure, or reduce migraine frequency, and no source cited here says otherwise
- Its documented role is trace mineral delivery through fulvic acid's chelation mechanism
- The clinical case for magnesium and migraine belongs to the oral magnesium trials, which did not use shilajit
- The postmenopausal magnesium loss case belongs to the estrogen trial, which also did not use shilajit
- A woman who wants the migraine question answered directly still needs the conversation grounded in the trials above, not a supplement claim standing in for them
The honest version of this story is a mineral delivery mechanism sitting downstream of two real, separate pieces of research, not a headline claim of its own. There have been zero serious adverse events ever reported across any human shilajit study, and Optimum sources its resin from the Altai mountains with every batch third party tested for heavy metals.
Common questions about magnesium and migraines
Does magnesium actually help with migraines?
A placebo controlled trial published in Cephalalgia gave 81 migraine patients 600 milligrams of oral magnesium daily for 12 weeks. By weeks 9 to 12, attack frequency had dropped 41.6 percent in the magnesium group versus 15.8 percent with placebo. A 2015 systematic review of the evidence concluded oral magnesium has real, if not overwhelming, support as a preventive option.
Why does magnesium run low specifically after menopause?
A controlled human trial found that postmenopausal women excreted significantly more magnesium in their urine than premenopausal women, and that giving estrogen therapy for two years brought that excretion back down to premenopausal levels. Estrogen appears to help the body hold onto magnesium, so its decline at menopause is tied to a measurable, documented increase in magnesium loss.
Does shilajit have a human trial proving it helps migraines?
No, and this article does not claim one exists. What shilajit's fulvic acid brings to this story is a mineral delivery mechanism, not a migraine specific clinical result. The migraine evidence above belongs to the oral magnesium trials, and the postmenopausal magnesium loss evidence belongs to the estrogen trial, both independent of shilajit.
How does fulvic acid help the body absorb magnesium?
Fulvic acid is a small, negatively charged molecule known to bind and chelate minerals, carrying them across the gut lining through the body's normal mineral transport pathways rather than relying on a harsher chemical reaction. That is a general absorption mechanism, and it has not been tested specifically against migraine outcomes.

Optimum Shilajit
Shilajit's fulvic acid is built to carry trace minerals, including magnesium, gently through the body's own absorption pathways, one box a day.
See Optimum ShilajitSources
- McNair P, Christiansen C, Transbol I. Effect of menopause and estrogen substitutional therapy on magnesium metabolism. Miner Electrolyte Metab. 1984;10(2):84-87. https://pubmed.ncbi.nlm.nih.gov/6608048/
- Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium, results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996;16(4):257-263. https://pubmed.ncbi.nlm.nih.gov/8792038/
- Teigen L, Boes CJ. An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia. 2015;35(10):912-922. https://pubmed.ncbi.nlm.nih.gov/25533715/
- Agarwal SP, et al. Shilajit: a review. Phytother Res. 2007;21(5):401-405. https://pubmed.ncbi.nlm.nih.gov/17295385/